These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 17698904

  • 1. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
    Catteau-Jonard S, Pigny P, Reyss AC, Decanter C, Poncelet E, Dewailly D.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4138-43. PubMed ID: 17698904
    [Abstract] [Full Text] [Related]

  • 2. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N.
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [Abstract] [Full Text] [Related]

  • 3. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J, Li R, Yu H, Zhao S, Yu Y, Qiao J.
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [Abstract] [Full Text] [Related]

  • 4. Anti-Müllerian hormone dynamics during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Dąbkowska-Huć A, Lemm M, Sikora J, Witek A, Skałba P.
    Endokrynol Pol; 2013 Apr; 64(3):203-7. PubMed ID: 23873424
    [Abstract] [Full Text] [Related]

  • 5. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 6. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Jul; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 7. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A, Abdelmeged A, El-Adawy AR, Eissa MK, Shaw RW, Amer SA.
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [Abstract] [Full Text] [Related]

  • 8. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014 Oct; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 9. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S, Schipper I, de Jong FH, Themmen AP, Visser JA, Laven JS.
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [Abstract] [Full Text] [Related]

  • 10. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
    Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5957-62. PubMed ID: 14671196
    [Abstract] [Full Text] [Related]

  • 11. The role of AMH in anovulation associated with PCOS: a hypothesis.
    Homburg R, Crawford G.
    Hum Reprod; 2014 Jun; 29(6):1117-21. PubMed ID: 24770999
    [Abstract] [Full Text] [Related]

  • 12. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
    Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
    [Abstract] [Full Text] [Related]

  • 13. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y, Wei LN, Xiong YL, Liang XY.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
    [Abstract] [Full Text] [Related]

  • 14. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS, Coffler MS, Malcom PJ, Chang RJ.
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [Abstract] [Full Text] [Related]

  • 15. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 16. Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients.
    Köninger A, Koch L, Enekwe A, Birdir C, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Gynecol Endocrinol; 2015 Jan; 31(1):26-30. PubMed ID: 25222840
    [Abstract] [Full Text] [Related]

  • 17. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
    Qi X, Pang Y, Qiao J.
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398
    [Abstract] [Full Text] [Related]

  • 18. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A, Sauter L, Edimiris P, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [Abstract] [Full Text] [Related]

  • 19. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
    Dewailly D, Robin G, Peigne M, Decanter C, Pigny P, Catteau-Jonard S.
    Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
    [Abstract] [Full Text] [Related]

  • 20. Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome.
    Schipper I, Rommerts FF, Ten Hacken PM, Fauser BC.
    J Clin Endocrinol Metab; 1997 May; 82(5):1325-31. PubMed ID: 9141511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.